Study of chemotherapy for weight loss in esophagus cancer
Part of Cancer, Digestive system clinical trials.
This study looks at chemotherapy for people with esophageal or stomach–esophagus junction cancer who are losing weight and muscle (cancer cachexia). It aims to see whether chemotherapy given before surgery can help in this situation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a man and age 18 or older
- You have esophageal or gastroesophageal junction cancer that is adenocarcinoma (a specific cancer type)
- Your doctors say you can get neoadjuvant FLOT chemotherapy before surgery (5-fluorouracil, oxaliplatin, docetaxel)
- Your cancer must be operable for surgery (not unresectable or metastatic)
- You must be able to sign consent and have health insurance
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of chemotherapy drugs given together with radiation therapy, followed by additional chemotherapy, for newly diagnosed adenocarcinoma (a type of cancer) in the esophagus or where the esophagus meets the stomach. The goal is to shrink the tumor and improve survival.
This study looks at different types of weight loss (cachexia) in people with advanced lung, pancreatic, or colorectal cancer. Researchers want to find patterns to better understand and treat it. You can join even if you haven't lost weight yet.
This trial tests a new appetite-boosting medicine (nano-crystalline megestrol acetate) added to standard chemotherapy for people with advanced small cell lung cancer who are losing weight. It aims to see if it helps with weight, strength, and treatment response.
This trial tests a shorter course of radiation combined with chemotherapy (FOLFOX) before surgery for esophageal or stomach-junction cancer. It aims to reduce side effects and still improve outcomes.
This study tests a new approach for people with advanced stomach or esophageal cancer who are losing weight and appetite. It combines a special form of a medicine (megestrol acetate) with standard chemotherapy and immunotherapy to see if it helps improve eating, weight, and quality of life.
This trial tests whether a medicine called megestrol acetate (an appetite stimulant) can help patients with stomach cancer who have lost weight (cachexia). The study combines this with standard chemotherapy and immunotherapy before surgery, aiming to improve nutrition and overall outcomes.
Hear when a new Esophageal Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.